“The collaboration will look into biomarkers within the blood, described as ‘fingerprints’,...
Unique panel of biomarkers identified for oesophageal cancer
Proteomics International Managing Director Dr Richard Lipscombe said the research studied multiple proteins in the blood associated with early-stage oesophageal adenocarcinoma. “From these, we’ve been able to identify a select panel of biomarkers with the potential to be used as a diagnostic test. Importantly we have also completed validation of the panel using blood samples from more than 300 patients.”
